24/7 Patient Assistance: 760-405-8205

Dianna Shipley, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

TriStar Centennial Medical Center

specialties & services

Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy

  • Bio & Insurance Information

    Dr. Shipley graduated the medical school from the Marshall University Joan C. Edwards. She did her internship at the Allegheny General Hospital-Western Pennsylvania Hospital and completed her residency program at the Charleston Area Medical Center. A fellowship followed at the Wake Forest University soon after that. She is specialized in Medical Oncology and board certified in Oncology. Dr. Shipley has been in practice for more than 20 years and is affiliated with the TriStar Centennial Medical Center. During her career, she has also contributed to various publications of medical interest.

    Insurance Accepted

    AetnaBlue Cross of CaliforniaBlue Shield of CaliforniaCignaFirst Health PPOHumanaMultiPlan

  • Education & Training

    dept_icon

    Marshall University Joan C. Edwards

    Medical School

    dept_icon

    Allegheny General Hospital - Western Pennsylvania Hospital

    Internship

    dept_icon

    Charleston Area Medical Center

    Residency

    dept_icon

    Wake Forest University

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    TriStar Centennial Medical Center

    Languages: English/Spanish

    (615) 342-1000

    2300 Patterson St

    Nashville, Tennessee 37203

    Read More
  • Publications & Memberships

    Dr. Dianna Shipley has contributed to 3 publications.

    Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer.

    Yardley DA, Shipley DL, Peacock NW, Shastry M, Midha R, Priego VM, Hainsworth JD; Breast Cancer Res. Treat.. 2015-08-01

    See more >>

    High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium.

    Hainsworth, J. D.,Shipley, D. L.,Reeves, J.,Arrowsmith, E. R.,Barnes, E. K.,Waterhouse, D. M.; Clin Genitourin Cancer. 2013 Sep.

    See more >>

    11 citations Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium.

    Hainsworth, J. D.,Waterhouse, D. M.,Penley, W. C.,Shipley, D. L.,Thompson, D. S.,Webb, C. D.,Anthony Greco, F.; Cancer Invest.. 2013 Jun.

    See more >>